When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LNTH - B. Riley assumes coverage on Lantheus Holdings with a buy
Lantheus Holdings Inc.
The strong launch of prostate cancer imaging agent Pylarify will aid in generating nearly double revenues in fiscal 2022, states B. Riley analyst Justin Walsh. Analyst further believes that the Lantheus (LNTH) -11% is well-positioned in the rapidly growing radiopharmaceutical space. B. Riley analyst Justin Walsh initiates coverage with a buy rating and set PT of $91. The target price of $91 is 57% higher than the current market price of $58.